Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,357
Views
0
CrossRef citations to date
0
Altmetric
Nephrology
Estimating health state utilities in primary hyperoxaluria type 1: a valuation study
Hayley M. de Freitasa Acaster Lloyd Consulting, London, UK
, David Daneseb Alnylam Pharmaceuticals, Cambridge, MA, USA
, Lena Hubiga Acaster Lloyd Consulting, London, UKhttps://orcid.org/0000-0002-9454-1232
, Andrew Lloyda Acaster Lloyd Consulting, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-7597-6556
& https://orcid.org/0000-0002-7597-6556
Stephen Lombardellib Alnylam Pharmaceuticals, Cambridge, MA, USA
Pages 386-393
|
Received 14 Oct 2022, Accepted 01 Feb 2023, Published online: 13 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.